Michele Cavo, M.D.^1*, Nicoletta Testoni, B.S.^1*, Carolina Terragna, B.S.^1*, Giulia Marzocchi, B.S.^1*, Sandra Durante, B.S.^1*, Renato Zambello, M.D.^2*, Chiara Nozzoli, M.D.^2*, Lucia Pantani, M.D.^1*, Paola Tacchetti, M.D.^1*, Luciano Masini, M.D.^2*, Michela Ceccolini, M.D.^1*, Paola Agostini, M.D.^2*, Elena Zamagni, M.D.^1*, Valerio De Stefano, M.D.^2*, Patrizia Tosi, M.D.^1*, Daniele Derudas, M.D.^2*, Laura Dessanti, M.D.^2*, Stelvio Ballanti, M.D.^2*, Salvatore Palmieri, M.D.^2*, Andrea Nozza, M.D.^2*, Gioacchino Catania, M.D.^2*, Jacopo Peccatori, M.D.^2*, Alfonso D'Arco, M.D.^2*, Pellegrino Musto, M.D.^2*, Mariella Grasso, M.D.^2*, Maria Caterina Pallotti, M.D.^1*, Silvana Pasini, M.D.^2*, Pier Paolo Fattori, M.D.^2*, Anna Baraldi, M.D.^2*, Delia Cangini, M.D.^2*, Filippo Ballerini, M.D.^2*, Alessandro Petrucci, M.D.^1* and Michele Baccarani, M.D.³

¹Seragnoli Institute of Hematology and Medical Oncology, Bologna University School of Medicine, Bologna, Italy
²Italian Myeloma Network GIMEMA, Italy
³Dept. Hematology and Medical Oncology, University of Bologna, Bologna, Italy

Soledad Molnar, MD^1*, Victor J Jimenez Zepeda^1*, Scott Van Wier^1*, Esteban Braggio^1*, Jonathan Keats^1*, Michael Kuehl^2*, Tammy Price-Troska^3*, Greg Ahmann^1*, Rachel Rempel^1*, Kim Henderson, MD^2*, S. Vincent Rajkumar, MD^4*, Philip . R Greipp, MD^3*, Daniel Auclair^5*, John Carpten^6*, Angela Baker^6*, Keith Stewart, MD¹, P. Leif Bergsagel, MD¹, Wee Joo Chng, MD^7* and Rafael Fonseca, MD¹

¹Hematology and Oncology, Mayo Clinic Arizona, Scottsdale, AZ
²Genetic Branchs, National Cancer Institute, Bethesda
³Mayo Clinic Rochester, Rochester, MN
⁴Hematology, College of Medicine, Mayo Clinic, Rochester, MN
⁵Multiple Myeloma Research Cancer
⁶Translational Genomics Research Institution, Phoenix, AZ
⁷Hematology and Oncology, National University Hospital of Singapure

Jayakumar R Nair, PhD^1*, Louise M Carlson, PhD^1*, Noreen Ersing, MS^2*, Asher Alban Chanan-Khan, MD³ and Kelvin P. Lee, MD⁴

¹Dept. of Immunology, Roswell Park Cancer Institute, Buffalo, NY
²Medicine, Roswell Park Cancer Institute, Buffalo, NY
³Medicine, Roswell Park Cancer Inst., Buffalo, NY
⁴Immunology, Roswell Park Cancer Institute, Buffalo, NY

Lia Perez, MD, Nancy Parquet^*, Claudio Anasetti^* and William Dalton^*

H. Lee Moffitt Cancer Ctr., Tampa, FL

Abdel kareem Azab^1*, Feda Azab^1*, Costas M Pitsillides^2*, Hai T. Ngo^1*, Xiaoying Jia^1*, Molly R. Melhem^1*, Judith Runnels^1*, Aldo M. Roccaro, MD, PhD¹, Antonio Sacco^1*, Nicholas Burwick^1*, Charles P Lin^2*, Kenneth C Anderson, MD³ and Irene M. Ghobrial^1*

¹Dana-Farber Cancer Inst., Boston, MA
²Wellman Center for Photomedicine, Massachusetts General Hospital, Boston, MA
³Jerome Lipper Multiple Myeloma Disease Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA

Dirk Hose¹, Thierry Rème^2*, Thomas Hielscher^3*, Jérôme Moreaux^2*, Tobias Meißner^1*, Anja Seckinger^1*, Axel Benner^3*, Michael Hundemer^1*, John Shaughnessy Jr.⁴, Bart Barlogie^4*, Jens Hillengass^1*, Uta Bertsch^1*, Anna Jauch^5*, Jean François Rossi^2*, Thomas Möhler^1*, Bernard Klein^6* and Hartmut Goldschmidt^1*

¹Medizinische Klinik V, Universitätsklinikum Heidelberg, Heidelberg, Germany
²CHU Montpellier and INSERM U475, Montpellier, France
³Abteilung für Biostatistik, Deutsches Krebsforschungszentrum, Heidelberg, Germany
⁴Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, AR
⁵Universitätsklinikum Heidelberg, Institut für Humangenetik, Heidelberg, Germany
⁶INSERM U847, Montpellier, France

Hagen S Bachmann, MD^1*, Juergen Novotny, MD^2*, Stephan Sixt, MD^3*, Peter Liebisch, MD^4*, Ulrich Frey, MD^3*, Juergen Peters, MD^3*, Ulrich Duehrsen, MD⁵, Winfried Siffert, MD^1* and Holger Nückel, MD^2*

¹Institute of Pharmacogenetics, University Hospital of Essen, Essen, Germany
²Department of Haematology, University Hospital of Essen, Essen, Germany
³Department of Anaesthesia and Intensive care, University Hospital of Essen, Essen, Germany
⁴Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany
⁵University Hospital Essen, Essen, Germany

Hirokazu Miki^1*, Shuji Ozaki², Osamu Tanaka^1*, Shingen Nakamura^1*, Ayako Nakano^1*, Kumiko Kagawa^1*, Kyoko Takeuchi^1*, Kenichiro Yata^1*, Masahiro Abe^1* and Toshio Matsumoto^1*

¹Department of Medicine and Bioregulatory Sciences, The University of Tokushima Graduate School of Health Biosciences, Tokushima, Japan
²Division of Transfusion Medicine, Tokushima University Hospital, Tokushima, Japan

Paul Mehan, MD^1*, Giridharan Ramsingh, MD², Jingqin Luo, Ph.D.^3*, Daniel Morgansztern, MD^2* and Ravi Vij, MD^2*

¹Internal Medicine, Washington University School of Medicine, St. Louis, MO
²Oncology, Washington University School of Medicine, Saint Louis, MO
³Biostatistics, Washington University School of Medicine, Saint Louis, MO

Nizar J Bahlis, MD¹, Alex Klimowicz, Ph.D.^2*, Paola Neri, M.D.^2*, Anthony Magliocco, M.D.^3*, Douglas A. Stewart, MD, FRCPC¹ and Adnan Mansoor, MD, FRCPC⁴

¹Hematology and Bone Marrow Transplantation, University of Calgary, Tom Baker Cancer Centre, Calgary, AB, Canada
²Medicine, University of Calgary, Calgary, AB, Canada
³Department of Oncology, Pathology and Laboratory Medicine, University of Calgary, University of Calgary, Calgary, AB, Canada
⁴Hematology and Transfusion Medicine, Calgary Laboratory services, University of Calgary, Calgary, AB, Canada

Celine M Vachon, PhD^1*, Robert Kyle, MD², Terry Therneau, PhD^1*, Dirk R Larson^1*, Colin Colby^1*, Barbara J Foreman^1*, Angela Dispenzieri, MD^3*, Shaji Kumar, MD³, Jerry Katzmann, MD^3* and S. Vincent Rajkumar, MD³

¹Health Sciences Research, Mayo Clinic, Rochester, MN
²Hematology, College of Medicine, Mayo Clinic, Rochester, MN
³Hematology, Mayo Clinic, Rochester, MN

Wee-Joo Chng¹, Gaofeng Huang^1*, Peter Leif Bergsagel, MD² and Rafael Fonseca, MD³

¹Haematology-Oncology, National University Hospital, Singapore, Singapore
²Mayo Clinic, Scottsdale, AZ
³Mayo Clinic Scottsdale, Scottsdale, AZ

Nicholas Burwick, MD^1*, Anne-Sophie Moreau, MD^1*, Xiaoying Jia^1*, Xavier Leleu, MD, PhD^1*, Judith Runnels^2*, Hai T. Ngo^1*, Molly R. Melhem^1*, Aldo M. Roccaro, MD, PhD¹, Abdel kareem Azab, PhD^1* and Irene M. Ghobrial, M.D.¹

¹Dana-Farber Cancer Institute, Boston, MA
²Dana-Farber Cancer Institute, Boston

David C Johnson^1*, Christine Ramos^2*, Alex J. Szubert^3*, Walter M Gregory^3*, J. Anthony Child^3*, Faith E Davies, MD¹, Brian GM Durie, MD⁴, Brian G. Van Ness, PhD² and Gareth J Morgan, MD, PhD¹

¹Section of Haemato-oncology, Institute of Cancer Research, London, United Kingdom
²University of Minnesota, Minneapolis, MN
³University of Leeds, Leeds, United Kingdom
⁴Hematology-Oncology Cedars-Sinai Outpatient Cancer Center at the Samuel Oschin Comprehensive Cancer Institute, Los Angeles, CA

Shikiko Ueno^1*, Hiro Tatetsu^1*, Hiroyuki Hata, MD, PhD¹, Tadafumi IIno^2*, Hiroaki Niiro^2*, Koichi Akashi, MD, PhD^2*, Daniel G. Tenen, MD³, Hiroaki Mitsuya^1* and Yutaka Okuno¹

¹Dept. of Hematology, Kumamoto Univ., Kumamoto, Japan
²Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Science, Fukuoka, Japan
³Harvard Inst. of Med., Boston, MA

Shaji Kumar¹, Lijun Zhang^2*, Angela Dispenzieri^1*, Scott Van Wier^3*, Jerry Katzmann^1*, Melissa Snyder^1*, Emily Blood^4*, Roberta DeGoey^1*, Kim Henderson^1*, Arthur Bradwell⁵, Robert Kyle^1*, Philip Greipp^1*, S.Vincent Rajkumar^1* and Rafael Fonseca^3*

¹Mayo Clinic, Rochester, MN
²Dana-Farber Cancer Institute, Boston, MA
³Hematology and oncology, Mayo Clinic Arizona, Scottsdale, AZ
⁴Dartmouth Medical School, Lebanon, NH
⁵Dept. of Immunology, Med. School, Univ. of Birmingham, Birmingham

Sigurdur Y Kristinsson, M.D.^1*, Magnus Bjorkholm, MD, PhD¹, Lynn R. Goldin, Ph.D.^2*, Cecilie Blimark, M.D.^3*, Ulf-Henrik Mellqvist, MD, PhD^3*, Anders Wahlin, MD, PhD^4*, Ingemar Turesson, MD, PhD^5* and Ola Landgren, M.D., Ph.D.²

¹Department of Medicine, Division of Hematology, Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden
²National Cancer Institute, National Institutes of Health, Bethesda, MD
³Department of Medicine, Section of Hematology and Coagulation, Sahlgrenska University Hospital, Gothenburg, Sweden
⁴Hematology, Umeå University Hospital, Umeå, Sweden
⁵Department of Medicine, Malmo University Hospital, Malmo, Sweden

Sonja I Berndt^1*, David C Johnson^2*, John Crowley³, Brian G Durie, MD⁴, Robert Hoover^1*, Michael Katz^5*, Nathaniel Rothman^1*, Brian G. Van Ness, PhD⁶, Dalsu Baris, MD, PhD^1* and Gareth J Morgan, MD, PhD⁷

¹Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD
²Section of Haemato-Oncology, Institute of Cancer Research, London, United Kingdom
³Southwest Oncology Group (SWOG) Statistical Center, Seattle, WA
⁴Hematology-Oncology Cedars-Sinai Outpatient Cancer Center at the Samuel Oschin Comprehensive Cancer Institute, Los Angeles, CA
⁵International Myeloma Foundation, North Hollywood, CA
⁶University of Minnesota, Minneapolis, MN
⁷Section of Haemato-Oncology, The Institute of Cancer Research, London, United Kingdom

Giuseppina Bonanno, BSc^1*, Maria Corallo, BSc^1*, Andrea Mariotti, BSc^1*, Anna Di Maggio, BSc^2*, Annabella Procoli, BSc^1*, Luca De Rosa, MD^3*, Luca Pierelli, MD^3*, Ignazio Majolino, MD³, Giuseppe Leone, MD^4*, Raimondo De Cristofaro, MD^2* and Sergio Rutella, MD, PhD⁴

¹Gynecology, Catholic University Medical School, Rome, Italy
²Medicine, Catholic University Medical School, Rome, Italy
³Ematologia, Ospedale S. Camillo, Rome, Italy
⁴Hematology, Catholic University Medical School, Rome, Italy

Ross D. Brown, PhD, MBA, Karieshma Kabani, BSc^*, Shihong Yang, MSc^*, Aklilu Esther, BSc^*, Phoebe Joy Ho, MBBS, DPhil, John Gibson, MBBS, PhD and Douglas E. Joshua, MBBS, DPhil

Haematology, Royal Prince Alfred Hospital, Camperdown, Australia

Wee-Joo Chng¹, Ian Lee^1*, Victor Jimenez-zepeda^2*, Esteban Braggio^2*, Jonathan Keats^2*, Peter Leif Bergsagel, MD² and Rafael Fonseca, MD²

¹Haematology-Oncology, National University Hospital, Singapore, Singapore
²Comprehensive Cancer Center, Mayo Clinic, Scottsdale, AZ

A. Broyl^1*, J. Peeters^2*, D. Hose³, Y. de Knegt^2*, B. Beverloo^4*, H. Lokhorst⁵, H. Goldschmidt^6*, M. van Duin^2* and P. Sonneveld²

¹Erasmus MC, Rotterdam, Netherlands
²Hematology, Erasmus Medical Center Rotterdam, Rotterdam, Netherlands
³Medizinische Klinik V, Universitätsklinikum Heidelberg, Heidelberg, Germany
⁴Clinical Genetics, Erasmus MC, Rotterdam, Netherlands
⁵Hematology, University Medical Center Utrecht, Utrecht, Netherlands
⁶Hematology, Oncology, Rheumatology, University of Heidelberg, Heidelberg, Germany

Marta Lionetti, PhD^*, Luca Agnelli^*, Laura Mosca, PhD^*, Katia Todoerti, PhD^*, Domenica Ronchetti, PhD^*, Sonia Fabris, PhD^*, Adrian Andronache, PhD^*, Donata Verdelli, PhD^*, Paola Ponzo, PhD^*, Giorgio Lambertenghi Deliliers, MD and Antonino Neri, MD^*

Department of Medical Science, Leukemia Study Center - Hematology 1, C.T.M.O., University of Milan - Fondazione IRCCS Policlinico, Milan, Italy

Kenichiro Yata^1*, Masahiro Abe^1*, Asuka Oda^1*, Hiroe Amou^1*, Masahiro Hiasa^2*, Kyoko Takeuchi^1*, Shingen Nakamura^1*, Osamu Tanaka^1*, Hirokazu Miki^1*, Ayako Nakano^1*, Kumiko Kagawa^1*, Shuji Ozaki³ and Toshio Matsumoto^1*

¹Department of Medicine and Bioregulatory Sciences, The University of Tokushima Graduate School of Health Biosciences, Tokushima, Japan
²Department of Biomaterials and Bioengineerings, The University of Tokushima Graduate School of Health Biosciences, Tokushima, Japan
³Division of Transfusion Medicine, Tokushima University Hospital, Tokushima, Japan

Tina Bagratuni^*, Ping Wu^*, David Gonzalez de Castro^*, Emma L Davenport^*, Brian A Walker^*, Matthew W Jenner^*, David C Johnson^*, Gareth J. Morgan and Faith E Davies^*

Section of Haemato-oncology, Institute of Cancer Research, London, United Kingdom

Simona Colla^1*, Paola Storti^1*, Gaetano Donofrio^2*, Mirca Lazzaretti^3*, Sabrina Bonomini^1*, Paolo Lunghi^4*, Monica Crugnola^1*, Marina Bolzoni^1*, Luisa Galla^1*, Luigi Ippolito^5*, Eugenia Martella^6*, Gabriella Sammarelli^1*, Luisa Craviotto^1*, Cecilia Caramatti^1*, Marcellina Mangoni^1*, Antonio Bonati^7*, Vittorio Rizzoli^1* and Nicola Giuliani¹

¹Unit of Hematology and BMT, University of Parma, Parma, Italy
²Dipartimento di Salute Animale, University of Parma, Parma, Italy
³Genetica, University of Parma, Parma, Italy
⁴Department of Clinical Sciences, University of Parma, Parma, Italy
⁵Laboratorio di Diagnostica Ematochimica, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy
⁶Pathology, University of Parma, Parma, Italy
⁷Department of Clinical Sciences and Unit of Hematology and BMT, University of Parma, Italy

Meral Beksac, MD^1*, Martin Maiers^2*, Loren Gragert^2*, Stephen Spellman^2*, Smriti Shrestha, MS, MA^3*, Mei-Jie Zhang, PhD^3*, Angela Dispenzieri, MD⁴, Donna E. Reece, MD⁵, David H. Vesole, MD, PhD^6* and Parameswaran Hari, MD, MS³

¹Hematology, Ankara University School of Medicine, Ankara, Turkey
²National Marrow Donor Program, Minneapolis, MN
³Medical College of Wisconsin, Center for International Blood and Marrow Transplant Research, Milwaukee, WI
⁴Mayo Clinic, Rochester, MN
⁵Medical Oncology and Hematology, Princess Margaret Hospital, Toronto, ON, Canada
⁶St. Vincent's Comprehensive Cancer Center, New York, NY

Ashutosh Wechalekar¹, Giampaolo Merlini^2*, Julian D Gillmore^1*, P. Russo^3*, Helen J Lachmann^1*, Laura Obici^3*, Philip N Hawkins^1* and Giovanni Palladini^2*

¹National Amyloidosis Center, University College London Medical School, London, United Kingdom
²Center for Amyloidosis, Fondazione IRCCS Policlinico San Matteo and Department of Biochemistry, University of Pavia, Italy
³Center for Amyloidosis, Fondazione IRCCS Policlinico San Matteo and Department of Biochemistry, Italy

Gullu Gorgun, PhD, Elisabetta Calabrese, MD^*, Teru Hideshima^*, Hiroshi Ikeda^*, Giulia Perrone^*, Loredana Santo^*, Diana Cirstea^*, Paul G Richardson^* and Kenneth C Anderson^*

Medical Oncology, Dana-Farber Cancer Institute, Boston, MA

Bijay Nair, PhD^1*, Yiming Zhou, PhD^1*, Bart Barlogie, MD, PhD¹, Jeffrey Sawyer, PhD^2*, Jackie Szymonifka^3*, John Crowley, PhD³ and John D. Shaughnessy Jr., PhD¹

¹Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, AR
²Pathology, University of Arkansas for Medical Sciences, Little Rock, AR
³Cancer Research & Biostatistics, Seattle, WA

Shaji Kumar, MD, Angela Dispenzieri^*, Dirk Larson^*, Colin Colby^*, Robert Kyle^*, Morie Gertz^* and S.Vincent Rajkumar^*

Hematology, Mayo Clinic, Rochester, MN

Brendan M Weiss, MD¹, Pramvir Verma, MD^2*, Jude Abadie, PhD^3*, Robin Howard, MA^4* and Michael Kuehl, MD^5*

¹Hematology-Oncology Service, Walter Reed Army Medical Center, Washington, DC
²Hematology-Oncology Service, Womack Army Medical Center, Fort Bragg, NC
³Pathology and Area Laboratory Services, Walter Reed Army Medical Center, Washington, DC
⁴Department of Clinical Investigation, Walter Reed Army Medical Center, Washington, DC
⁵Genetics Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD

Carolina Elosua^1*, Purificacion Catalina^1*, Brian A Walker^2*, Nicholas J Dickens^2*, Athanasia Avramidou^2*, Luis Brito^2*, Emma Davenport, PhD^2*, Matthew W Jenner^2*, David Gonzalez, PhD^2*, Faith Davies, MD², Gareth J Morgan, MD, PhD² and Paola E Leone, PhD^1*

¹Multiple Myeloma Group, Andalusian Stem Cell Bank, Granada, Spain
²Section of Haemato-Oncology, The Institute of Cancer Research, London, United Kingdom

Bangzheng Chen, PhD, Hong Wu^*, Yuxin Zeng^*, John E Freeman III^*, Damir Herman^*, John D. Shaughnessy Jr., Bart Barlogie and Joshua Epstein

Myeloma Institute for Research and Therapy, Little Rock, AR

Hang Quach, MB, BS, FRACP, FRCPA^1*, David Ritchie, MBChB, FRACP, FRCPA, PhD^2*, Paul Neeson, PhD^3*, Simon Harrison, MB, BS, MRCP, MRCPath, PhD^2*, Tsin Tai, MSc^4*, Kellie Tainton, BSc^4*, Kevin Lynch, MB, BS, FFPM^5* and Miles Prince, MB, BS, FRACP, FRCPA, MRACMA, MD⁶

¹Dept. of Haematology and Clinical Oncology., Peter MacCallum Cancer Centre, Melbourne, Australia
²Dept. of Haematology and Clinical Oncology, Peter MacCallum Cancer Center, Melbourne, Australia
³Haematology Immunology Translational Research Laboratory, Immunology Program, Peter MacCallum Cancer Center, Melbourne, Australia
⁴Haematology Immunology Translational Research Laboratory, Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Australia
⁵Celgene Pty Ltd, Melbourne, Australia
⁶Dept. of Haematology and Clinical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia

Yu Hu^1*, Chun-yan Sun^1*, Jing Huang^1*, Lu Zhang^1*, Zhang-bo Chu^1* and Shiang Huang, MD²

¹Institute of Hematology, Union Hospital, Tongji medical college, Huazhong University of Science and Technology, Wuhan, China
²Institute of Hematology, Union Hospital, Tongji Medical School, Huazhong University of Science and Technology, Wuhan, China

Masayoshi Kobune, MD, PhD, Kazuyuki Murase, MD, PhD^*, Satoshi Iyama, MD, PhD^*, Tsutomu Sato, MD, PhD^*, Yutaka Kawano, MD, PhD^*, Shohei Kikuchi, MD, PhD^*, Koji Miyanishi, MD, PhD^*, Rishu Takimoto, MD, PhD^* and Junji Kato, MD, PhD^*

Fourth Dept. of Internal Med., Sapporo Medical University, Sapporo, Japan

Robert P. Evans, Ph.D.^1*, Kim Laginha^1*, Linda M. Pilarski, PhD², Andrew Belch, MD³ and Tony Reiman, MD³

¹Oncology, Cross Cancer Institute & University of Alberta, Edmonton, AB, Canada
²University of Alberta & Cross Cancer Institute, Edmonton, AB, Canada
³Cross Cancer Institute, Edmonton, AB, Canada

Shuo Ma, MD, PhD^1*, Fenghuang Zhan, MD, PhD^2*, Chunguang Ma^1*, Michael Tessel^1*, Lijun Zhang^3*, S. Vincent Rajkumar, MD^4*, Seema Singhal⁵, Bart Barlogie, MD^6*, John Shaughnessy, PhD⁷, Steven T. Rosen, MD⁸ and Nancy Krett, PhD^1*

¹Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL
²Blood/Marrow Transplant and Myeloma Program, University of Utah School of Medicine, Salt Lake City, UT
³Dana-Farber Cancer Institute, Boston, MA
⁴Hematology, Mayo Clinic, Rochester, MN
⁵Hem./Onc., Northwestern Univ. Med. School, Chicago, IL
⁶Myeloma Institute for Research and Therapy, University of Arkansas for Medical Science, Little Rock, AR
⁷Dept. of Medicine, Univ. of AR for Med. Sciences, Little Rock, AR
⁸Northwestern University, Robert H. Lurie Comprehensive Cancer Center, Chicago, IL

Ha-Yon Kim^*, Seong-Woo Kim^*, Hyo-Jin Lee, MD, PhD^*, Hwan-Jung Yun, MD^*, Samyong Kim, MD, PhD^* and Deog-Yeon Jo, MD, PhD

Department of Internal Medicine and Cancer Research Institute, College of Medicine, Chungnam National University, Daejeon, South Korea

Hong Chang, MD¹, Connie Qi, MD^2*, Allan Jiang^1*, Wei Xu, PhD^3*, Young Trieu, MSc^4* and Donna E. Reece, MD⁴

¹University Health Network, Toronto, ON, Canada
²UNIVERSITY HEALTH NETWORK, Toronto, ON, Canada
³Biostatistics, Princess Margaret Hospital, Toronto, ON, Canada
⁴Medical Oncology and Hematology, Princess Margaret Hospital, Toronto, ON, Canada

Jo Caers^1*, Dirk Hose², Ine Kuipers^1*, Tomas Jan Bos^1*, Els Van Valckenborgh^1*, Eline Menu^1*, Elke De Bruyne^1*, Hartmut Goldschmidt^2*, Ben Van Camp^1*, Bernard Klein^3* and Karin Vanderkerken¹

¹Hematology and Immunology, Vrije Universiteit Brussel, Brussels, Belgium
²GMMG and University of Heidelberg, Heidelberg, Germany
³INSERM U847, Montpellier, France

Sophia Adamia, Ph.D^1*, Samir B Amin, MBBS^2*, Cheng Li, Ph.D^3*, Christopher J Patterson^4*, Herve AvetLoiseau, MD^5*, Stephane Minvielle, Ph.D^5*, Philippe Moreau, MD^5*, Kenneth C Anderson, MD⁶, Nikhil C. Munshi, MD⁷ and Steven Treon, MD, PhD⁸

¹Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
²Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
³Department of Biostatistics and Department of Biostatistics and Computational Biology, Harvard School of Public Health and Dana-Farber Cancer Institute, Boston
⁴Waldenstrom's macroglubulinemia center, Dana-Farber Cancer Institute, Boston, MA
⁵Hematology Department, Hopital de Nantes, Nantes, France
⁶Jerome Lipper Multiple Myeloma Disease Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
⁷Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston VA Cancer Healthcare System, Boston, MA
⁸Dana-Farber Cancer Institute, Boston, MA

Ricky D Edmondson, PhD^*, Sheeno P Thyparambil, Ph.D.^*, Veronica MacLeod^*, Bart Barlogie, MD, PhD and John D. Shaughnessy Jr., PhD

Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, AR

Kenneth H Shain, M.D., Ph.D.¹, Danielle Yarde^2*, Mark Mead, Ph.D.^2*, Lori Hazlehurst, Ph.D.^2* and William S Dalton, M.D., Ph.D^1*

¹Hematology Oncology and Experimental Therapeutics, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL
²Experimental Therapeutics, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL

Bonnie K Arendt^1*, Xiaosheng Wu, MD^1*, Philip R Greipp, MD^2*, S. Vincent Rajkumar, MD^2*, Robert Kyle, MD², Rhett P Ketterling, MD^3*, Ryan A Knudson^3* and Diane F Jelinek^1*

¹Immunology, College of Medicine, Mayo Clinic, Rochester, MN
²Hematology, College of Medicine, Mayo Clinic, Rochester, MN
³Laboratory Medicine and Pathology, College of Medicine, Mayo Clinic, Rochester, MN